ESMO 2018: Melanoma highlights
ESMO 2018: Melanoma highlights
IMpower130: PFS and safety of adding atezolizumab to first-line NSCLC therapy
KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma
ESMO 2018: Highlights
Advances in metastatic non small cell lung cancer
Detecting copy number alterations using a pre-natal test
PEACE: Collecting cancer tissue to solve the riddle of metastasis
Comment on new treatment options for breast cancer
PALOMA-3 update, including OS data for HR positive HER2 negative breast cancer
New therapeutic options in advanced and metastatic breast cancer
Editor’s Choice for September 2018
The microbiome – a novel paradigm in oncology research